Literature DB >> 19640674

Prevalence of osteonecrosis of the femoral head: a nationwide epidemiologic analysis in Korea.

Joon Soon Kang1, Sohee Park, Joo Hyoun Song, Yung Yul Jung, Myung Rae Cho, Kee Hyung Rhyu.   

Abstract

This study was performed to estimate the prevalence of osteonecrosis of the femoral head in Korea. Using medical claims data from the Korean National Health Insurance Corporation, all individuals treated under a diagnosis of osteonecrosis of the femoral head were identified for each year from 2002 to 2006. Among them, the number of true cases was estimated using a randomly collected validation sample of 382 patients for which the actual diagnosis was investigated by authors. The estimated yearly prevalence per 100 000 population ranged from 20.53 (20.13 <or= 95% confidence interval <or= 20.94) in 2002 to 37.96 (37.42 <or= 95% confidence interval <or= 38.51) in 2006. The average estimated number of annual prevalent cases was 14 103, indicating 28.91 per 100 000 average prevalence over a 5-year period. Males predominated. We found that 32.4% had history of alcohol abuse, and 14.6% was related to steroid. Bilateral involvement was noticed in 37%. Besides arthroplasty, decompression was the most frequently performed joint-preserving procedure. We believe that the results serve as important baseline for understanding the disease.

Entities:  

Mesh:

Year:  2009        PMID: 19640674     DOI: 10.1016/j.arth.2009.05.022

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  46 in total

1.  Problems with the pathological diagnosis of osteonecrosis.

Authors:  Shobha Parajuli; John R Fowler; Easwaran Balasubramanian; William R Reinus; John P Gaughan; Daniel I Rosenthal; Jasvir S Khurana
Journal:  Skeletal Radiol       Date:  2016-01       Impact factor: 2.199

2.  miR-10a-5p, miR-99a-5p and miR-21-5p are steroid-responsive circulating microRNAs.

Authors:  Zheng Li; Chao Jiang; Canhua Ye; Shibai Zhu; Xi Chen; William Kk Wu; Wenwei Qian
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 3.  Clinical effect of hyperbaric oxygen therapy in the treatment of femoral head necrosis : A systematic review and meta-analysis.

Authors:  Wei Li; Ziliang Ye; Wei Wang; Kun Wang; Lang Li; Dewei Zhao
Journal:  Orthopade       Date:  2017-05       Impact factor: 1.087

4.  Lipid metabolism abnormalities in alcohol-treated rabbits: a morphometric and haematologic study comparing high and low alcohol doses.

Authors:  Satoshi Ikemura; Takuaki Yamamoto; Goro Motomura; Kenyu Iwasaki; Ryosuke Yamaguchi; Garida Zhao; Yukihide Iwamoto
Journal:  Int J Exp Pathol       Date:  2011-06-07       Impact factor: 1.925

5.  Progranulin Protects Against Osteonecrosis of the Femoral Head by Activating ERK1/2 Pathway.

Authors:  Yingguang Han; Meng Si; Yunpeng Zhao; Yi Liu; Kaiyuan Cheng; Yuedong Zhang; Jialin Jia; Jingkun Li; Lin Nie
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

6.  Chinese Guideline for the Diagnosis and Treatment of Osteonecrosis of the Femoral Head in Adults.

Authors: 
Journal:  Orthop Surg       Date:  2017-02       Impact factor: 2.071

7.  Alcohol intake and the risk of osteonecrosis of the femoral head in Japanese populations: a dose-response meta-analysis of case-control studies.

Authors:  Byung-Ho Yoon; Tae-Young Kim; In-Soo Shin; Hee Young Lee; Yun Jong Lee; Kyung-Hoi Koo
Journal:  Clin Rheumatol       Date:  2017-07-06       Impact factor: 2.980

8.  Alcohol and bone.

Authors:  Peter Mikosch
Journal:  Wien Med Wochenschr       Date:  2014-01-30

9.  Multicentric epidemiologic study on six thousand three hundred and ninety five cases of femoral head osteonecrosis in China.

Authors:  Liqiang Cui; Qianyu Zhuang; Jin Lin; Jin Jin; Ke Zhang; Li Cao; Jianhao Lin; Shigui Yan; Wanshou Guo; Wei He; Fuxing Pei; Yixin Zhou; Xisheng Weng
Journal:  Int Orthop       Date:  2015-12-14       Impact factor: 3.075

10.  Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study.

Authors:  Young Bin Joo; Yoon-Kyoung Sung; Jee-Seon Shim; Jae-Hoon Kim; Eui-Kyung Lee; Hye-Soon Lee; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2014-10-10       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.